Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism

Jun Wu; Or Kakhlon; Miguel Weil; Alexander Lossos; Berge A. Minassian

doi:10.1038/s44321-024-00063-9

Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism

Jun Wu, Or Kakhlon, Miguel Weil, Alexander Lossos, Berge A. Minassian

Tel Aviv University, The Hebrew University of Jerusalem

Research output: Contribution to journal › Letter › peer-review

Abstract

In this Correspondence, B. Minassian and colleagues report that GHF201, an autophagy activator shown to diminish abnormal glycogen aggregates in a mouse model of Adult Polyglucosan Body Disease, fails to reduce such accumulations in a mouse model of Lafora disease. (Figure presented.)

Original language	English
Pages (from-to)	1047-1050
Number of pages	4
Journal	EMBO Molecular Medicine
Volume	16
Issue number	5
DOIs	https://doi.org/10.1038/s44321-024-00063-9
State	Published - 16 May 2024

All Science Journal Classification (ASJC) codes

Molecular Medicine

Access to Document

10.1038/s44321-024-00063-9

Cite this

@article{6de3595e0971491e97d826d335032c00,

title = "Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism",

abstract = "In this Correspondence, B. Minassian and colleagues report that GHF201, an autophagy activator shown to diminish abnormal glycogen aggregates in a mouse model of Adult Polyglucosan Body Disease, fails to reduce such accumulations in a mouse model of Lafora disease. (Figure presented.)",

author = "Jun Wu and Or Kakhlon and Miguel Weil and Alexander Lossos and Minassian, \{Berge A.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = may,

day = "16",

doi = "10.1038/s44321-024-00063-9",

language = "الإنجليزيّة",

volume = "16",

pages = "1047--1050",

journal = "EMBO Molecular Medicine",

issn = "1757-4676",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "5",

}

TY - JOUR

T1 - Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism

AU - Wu, Jun

AU - Kakhlon, Or

AU - Weil, Miguel

AU - Lossos, Alexander

AU - Minassian, Berge A.

PY - 2024/5/16

Y1 - 2024/5/16

N2 - In this Correspondence, B. Minassian and colleagues report that GHF201, an autophagy activator shown to diminish abnormal glycogen aggregates in a mouse model of Adult Polyglucosan Body Disease, fails to reduce such accumulations in a mouse model of Lafora disease. (Figure presented.)

AB - In this Correspondence, B. Minassian and colleagues report that GHF201, an autophagy activator shown to diminish abnormal glycogen aggregates in a mouse model of Adult Polyglucosan Body Disease, fails to reduce such accumulations in a mouse model of Lafora disease. (Figure presented.)

UR - http://www.scopus.com/inward/record.url?scp=85189205127&partnerID=8YFLogxK

U2 - 10.1038/s44321-024-00063-9

DO - 10.1038/s44321-024-00063-9

M3 - رسالة

C2 - 38565807

SN - 1757-4676

VL - 16

SP - 1047

EP - 1050

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

IS - 5

ER -

Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this